• Yeast Search


    Search
  • Full Catalogue
  • Type Strains
  • Brewing Strains

    Search
  • Baking Strains
  • Spec. Application
    Strains +

    Search
  • Genetically Defined Strains
  • SGRP Strains +/-

NCYC 1363

Candida albicans

Pre 2011 Name

Candida albicans

Equivalent Strain Designations

ATCC 10231, CBS 6431,CCY 29-3-106, CIP 48.72, DSM 1386, IFO 1594, NCPF 3179, NIH 3147, VTT C-85161.

Depositor

ATCC

Deposit Date

Unknown 1981

Habitat

Man with bronchomycosis
Candida albicans

Details

Candida albicans

A licence fee may be applied to products purchased for commercial use. Find out more information.



Add to Basket



Key Information

Aerobic Utilisation and Growth

  • Glucose +
  • Galactose +
  • Sorbose +
  • Sucrose +
  • Maltose +
  • Cellobiose -
  • Trehalose +
  • Lactose -
  • Melibiose -
  • Raffinose -
  • Melezitose +
  • Inulun -
  • Soluble Starch -
  • Xylose +
  • L Arabinose -
  • D Arabinose -
  • Ribose -
  • Rhamnose -
  • Ethanol +
  • Glycerol +
  • Erythritol -
  • Ribitol +
  • Galactitol -
  • Mannitol +
  • Sorbitol +
  • AMD Glucoside +
  • Salicin -
  • Lactic Acid +
  • Succinic Acid +
  • Citric Acid -
  • Inositol -
  • GluconolactoneUnknown
  • GlucosamineUnknown
  • MethanolUnknown
  • XylitolUnknown

Strain Information

  • Information

    Applications: Assay of amphotericin B, haloprogin, nystatin; testing antimicrobial preservatives;sterility testing. Produces: Farnesoic acid, D-arabinolactone oxidase, DNA topoisomerase, aspartic proteinases (aspartyl proteinases) , estrogen-binding protein, lanosterol synthase (2,3-oxidosqualene lanosterol cyclase), phenethyl alcohol, polyamine oxidase, tryptophol.

  • DepositorATCC
  • Deposit NameCandida albicans
  • Month of depositUnknown
  • Deposit Year1981
  • HabitatMan with bronchomycosis
  • Equivalent Strain DesignationsATCC 10231, CBS 6431,CCY 29-3-106, CIP 48.72, DSM 1386, IFO 1594, NCPF 3179, NIH 3147, VTT C-85161.
  • ReferenceAssay of haloprogin, amphotericin B, nystatin (Can.J.Microbiol., 1980, 20, 1241); sterility testing (US Pharmacopoeia, 1980, 20th rev., 878-879); assay of anti-microbial preservatives (US Pharmacopoeia, 1980, 20th rev., 873-874; British Pharmacopoeia, 2, A193); produces phenethyl alcohol and tryptophol (Science, 1969, 163, 192-194). Lingappa BT , et al. Phenethyl alcohol and tryptophol: autoantibiotics produced by the fungus Candida albicans. Science 163: 192-194, 1969. Skowronski R , Feldman D . Characterization of an estrogen-binding protein in the yeast Candida albicans. Endocrinology 124: 1965-1972, 1989. Connolly P , et al. The use of impedance for preservative efficacy testing of pharmaceuticals and cosmetic products. J. Appl. Bacteriol. 76: 68-74, 1994. Klig LS , et al. Comparison of INO1 gene sequences and products in Candida albicans and Saccharomyces cerevisiae. Yeast 10: 789-800, 1994. ASTM International. Standard test method for preservatives in water-containing cosmetics. West Conshohocken, PA: ASTM International; ASTM Standard Test Method E640-78. British Pharmacopoeia Commission. Tests for microbial contamination. In: British Pharmacopoeia 1993. vol. 2: London (UK): British Pharmacopoeia Commission; 1993, Appendix XVI B, pp. A184-A190. British Pharmacopoeia Commission. Efficacy of antimicrobial preservation. In: British Pharmacopoeia 1993. vol. 2: London (UK): British Pharmacopoeia Commission; 1993, Appendix XVI C, pp. A191-A192. Gershon H , Shanks L . Antifungal properties of n-alkanols, alpha, omega-n-alkanediols, and omega-chloro-alpha-alkanols. J. Pharm. Sci. 69: 381-384, 1980. Shen LL , et al. DNA topoisomerases from pathogenic fungi: targets for the discovery of antifungal drugs. Antimicrob. Agents Chemother. 36: 2778-2784, 1992. Wagner T , et al. pH-dependent denaturation of extracellular aspartic proteinases from Candida species. J. Med. Vet. Mycol. 33: 275-278, 1995. Rudek W . Esterase activity in Candida species. J. Clin. Microbiol. 8: 756-759, 1978. Phillips AW , Balish E . Growth and invasiveness of Candida albicans in the germ-free and conventional mouse after oral challenge. Appl. Microbiol. 14: 737-741, 1966. Zygmunt WA , Tavormina PA . Steroid interference with antifungal activity of polyene antibiotics. Appl. Microbiol. 14: 865-869, 1966. Ghannoum MA , Al-Khars A . Effect of antineoplastic agents on the growth and ultrastructure of Candida albicans. Mykosen 27: 452-464, 1984. Dev. Ind. Microbiol. 21: 373-378, 1980. Saltarelli CG . Morphological and physiological variations between sectors isolated from giant colonies of Candida albicans and C. stellatoidea. Mycopathol. Mycol. Appl. 34: 209-220, 1968. Braun PC . Surface hydrophobicity enhances corticosterone incorporation in Candida albicans. Infect. Immun. 62: 4087-4090, 1994. Balish E , Svihla G . Ultraviolet microscopy of Candida albicans. J. Bacteriol. 92: 1812-1820, 1966. Balliano G , et al. Inhibition of sterol biosynthesis in Saccharomyces cerevisiae and Candida albicans by 22,23-epoxy-2-aza-2,3-dihydrosqualene and the corresponding N-oxide. Antimicrob. Agents Chemother. 38: 1904-1908, 1994. Huh WK , et al. Characterisation of D-arabinono-1,4-lactone oxidase from Candida albicans ATCC 10231. Eur. J. Biochem. 225: 1073-1079, 1994. Ennever J , Summers FE . Calcification by Candida albicans. J. Bacteriol. 122: 1391-1393, 1975. Lerner CG , Goldman RC . Stimuli that induce production of Candida albicans extracellular aspartyl proteinase. J. Gen. Microbiol. 139: 1643-1651, 1993. ASTM International. Standard test method for evaluation of antimicrobial agents as preservatives for invert emulsion and other water containing hydraulic fluids. West Conshohocken, PA: ASTM International; ASTM Standard Test Method E979-91. European Pharmacopoeia Commission. Microbial contamination of products not required to comply with the test for sterility (total viable aerobic count). In: European Pharmacopoeia. 3rd ed. Strasbourg, France: European Pharmacopoeia Commission; 1997, EP 2.6.12. European Pharmacopoeia Commission. Efficacy of antimicrobial preservation. In: European Pharmacopoeia. 3rd ed. Strasbourg, France: European Pharmacopoeia Commission; 1997, EP 5.1.3. NCCLS. Quality assurance for commercially prepared microbiological culture media. 2nd ed.. Wayne, PA: NCCLS; NCCLS M22-A2, 1996. US Food & Drug Administration. General biological products standards; general provisions; sterility. Code of Federal Regulations Title 21: Part 610, Subpart B. U.S. Pharmacopeia. Antimicrobial preservatives - effectiveness. In: U.S. Pharmacopeia. 23rd rev. Rockville, MD: U.S. Pharmacopeia; 1995, <51>, p. 1681. U.S. Pharmacopeia. Sterility tests. In: U.S. Pharmacopeia. 23rd rev. Rockville, MD: U.S. Pharmacopeia; 1995, <71>, pp. 1686-1690. U.S. Pharmacopeia. Microbial limit tests - Nutritional supplements - Preparatory testing. In: U.S. Pharmacopeia. 23rd rev. Rockville, MD: U.S. Pharmacopeia; 1995, <2021>, p. 2180. Kondoh O , et al. Cloning of the RHO1 gene from Candida albicans and its regulation of beta-1,3-glucan synthesis. J. Bacteriol. 179: 7734-7741, 1997. Huh WK , Kang SO . Molecular cloning and functional expression of alternative oxidase from Candida albicans. J. Bacteriol. 181: 4098-4102, 1999. Oh KB , et al. Purification and characterization of an autoregulatory substance capable of regulating the morphological transition in Candida albicans. Proc. Natl. Acad. Sci. USA 98: 4664-4668, 2001. Isobe K , et al.. Differential determination procedure for putrescine, spermidine and spermine with polyamine oxidase from fungi and putrescine oxidase. Agric. Biol. Chem. 45: 727-733, 1981. Yamada H , et al.. Oxidation of polyamines by fungal enzymes. Agric. Biol. Chem. 44: 2469-2476, 1980. Bowman FW , et al. Collaborative study of aerobic media for sterility testing by membrane filtration. J. Pharm. Sci. 60: 1087-1088, 1971. Harrison EF , Zygmunt WA . Haloprogin: Mode of action studies in Candida albicans. Can. J. Microbiol. 20: 1241-1245, 1974.

Physical Characteristics

  • Optimum TemperatureUnknown
  • Miniumum TemperatureUnknown
  • Maximum TemperatureUnknown

Cells

  • ShapeRound-oval
  • Min Broth Breadth (µm)3
  • Max Broth Breadth (µm)6
  • Min Broth Length (µm)3
  • Max Broth Length (µm)7
  • Min Agar Breadth (µm)3
  • Max Agar Breadth (µm)6
  • Min Agar Length (µm)3
  • Max Agar Length (µm)7
  • ArrangementPairs
  • Colour on AgarUnknown
  • Surface on AgarUnknown
  • Texture on AgarUnknown
  • Deposit in BrothUnknown
  • Ring in BrothAbsent
  • Ring ColourUnknown
  • Pellicle in BrothAbsent
  • Pellicle AppearanceN/A
  • Pellicle HabitatN/A

Cell Division

  • BuddingMultipolar
  • FissionAbsent

Filamentous Growth

  • PseudomyceliumWell formed
  • Pseudomycelium BranchUnknown
  • Pseudomycelium FormUnknown
  • BlastosporesMany
  • Blastospore ShapeUnknown
  • Blastospore LocationVerticils
  • Blastospore HabitatUnknown
  • True MyceliumPresent
  • Clamp ConnectionsAbsent

Asexual Spores

  • BallistosporesAbsent
  • AthrosporesAbsent
  • EndosporesAbsent
  • ChlamydosporesPresent

Sexual Spores

  • AscosporesAbsent
  • Ascospore ShapeN/A
  • Ascospore WallN/A
  • Ascospores No Per AscusN/A
  • Ascus ShapeN/A
  • ConjugationAbsent
  • TeliosporesAbsent
  • Teliospore ShapeN/A

Miscellaneous

  • AssayUnknown
  • Salt TolerantUnknown
  • KillerUnknown
  • PlasmidUnknown

Semi-Anaerobic Fermentation

  • GlucoseWeak/Latent
  • GalactoseWeak/Latent
  • Sucrose -
  • MaltoseWeak/Latent
  • Cellobiose -
  • TrehaloseWeak/Latent
  • Lactose -
  • Melibiose -
  • Raffinose -
  • Melizitose -
  • Inulin -
  • Soluble Starch -
  • XyloseUnknown
  • AMD Glucoside -

Aerobic Utilisation and Growth - Sole Sources of Nitrogen

  • NH4 2SO4 +
  • KNO3 -
  • Ethylamine +
  • CadaverineUnknown
  • LysineUnknown

Other

  • Vitamin Free Growth -
  • Cyclohex 100 +
  • Cyclohex 1000Unknown
  • Glucose Growth 50 -
  • Glucose Growth 60 -
  • Lipolytic +
  • Acid ProductionWeak/Latent
  • Growth 37 +
  • Growth 40Unknown
  • Arbutin Hydrolysis -
  • Urease Activity -
  • Starch Production -
  • Acid TolerantUnknown

Genomic Sequence Data

No data